References
Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA (2007) The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 164:942–948
Faraone SV, Biederman J, Spencer T, Wilens T, Seidman LJ, Mick E, Doyle AE (2000) Attention-deficit/hyperactivity disorder in adults: an overview. Biol Psychiatry 48:9–20
Bolea-Alamañac B, Nutt DJ, Adamou M, Asherson P, Bazire S, Coghill D, Heal D, Müller U, Nash J, Santosh P, Sayal K, Sonuga-Barke E, Young SJ, British Association for Psychopharmacology (2014) Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology. J Psychopharmacol 28:179–203
NICE clinical guidelines CG72. Attention deficit hyperactivity disorder: Diagnosis and management of ADHD in children, young people and adults. National Institute for Health and Care Excellence 2008. Available (November 2015), http://www.nice.org.uk/guidance/cg72
Štuhec M, Švab V, Locatelli I (2015) Prevalence and incidence of attention-deficit/hyperactivity disorder in Slovenian children and adolescents: a database study from a national perspective. Croat Med J 56:159–165
Štuhec M, Locatelli I, Švab V (2015) Trends in attention-deficit/hyperactivity disorder drug consumption in children and adolescents in slovenia from 2001 to 2012: a drug use study from a national perspective. J Child Adolesc Psychopharmacol 25:254–259
Schubert I, Köster I, Lehmkuhl G (2010) The changing prevalence of attention-deficit/hyperactivity disorder and methylphenidate prescriptions: a study of data from a random sample of insures of the AOK Health Insurance Company in the German State of Hesse, 2000–2007. Dtsch Arztebl Int 107:615–621
Štuhec M (2015) Hyperkinetic syndrome: from epidemiology to pharmacotherapy. Farmacevtskivestnik 66:177–184
Stuhec M, Munda B, Svab V, Locatelli I (2015) Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropion. J Affect Disord 178:149–159
Roskell NS, Setyawan J, Zimovetz EA, Hodgkins P (2014) Systematic evidence synthesis of treatments for ADHD in children and adolescents: indirect treatment comparisons of lisdexamfetamine with methylphenidate and atomoxetine. Curr Med Res Opin 30:1673–1685
Hervas A, Huss M, Johnson M, McNicholas F, van Stralen J, Sreckovic S, Lyne A, Bloomfield R, Sikirica V, Robertson B (2014) Efficacy and safety of extended-release guanfacine hydrochloride in children and adolescents with attention-deficit/hyperactivity disorder: a randomized, controlled, phase III trial. Euro Neuropsychopharmacol 12:1861–1872
Rights and permissions
About this article
Cite this article
Pharmacotherapy of ADHD in Slovenia: realities and perspectives. Eur Child Adolesc Psychiatry 25, 455–457 (2016). https://doi.org/10.1007/s00787-015-0811-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00787-015-0811-4